Bryan Reasons Insider Profile

4 Followers
Bryan Reasons, CFO at Amneal Pharmaceuticals, holds 28.73K shares in Aclaris Therapeutics (Ticker: ACRS), holds 0.00 shares in Societal CDMO (Ticker: SCTL), holds 96.66K shares in Mallinckrodt public limited company (Ticker: MNKTQ).
tipranks
Bryan Reasons

Bryan Reasons
Amneal Pharmaceuticals (AMRX)
CFO

Not Ranked
Ranked #94,879 out of 99,218 Corporate Insiders
Bryan Reasons has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$64K
100.00%
0.00%
A breakdown of Bryan Reasons's holdings

Insider Roles

Aclaris Therapeutics
(ACRS)
Director
Amneal Pharmaceuticals
(AMRX)
CFO
Roles that Bryan Reasons holds in companies

Most Profitable Insider Trade

Stock:
Mallinckrodt
(MNKKQ)
Rating:Informative Buy
Date:Jun 07, 2019 - Jun 07, 2020
Return:-69.60%
The most profitable trade made by Bryan Reasons

Bryan Reasons's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Amneal Pharmaceuticals
May 08, 2018
CFO
Uninformative Sell
$0.00
SCTL
Societal CDMO
Apr 08, 2024
Uninformative Sell
320.15K
$0.00
Aclaris Therapeutics
Jun 04, 2024
Director
Uninformative Buy
4.80K
$63.79K
MNKKQ
Mallinckrodt
Jun 21, 2022
Uninformative Sell
$0.00
MNKTQ
Mallinckrodt public limited company
Aug 18, 2023
Uninformative Sell
11.02K
$11.60K
List of latest transactions for each holding click on a transaction to see Bryan Reasons's performance on stock

Bryan Reasons insider profile FAQ

What is the percentage of profitable transactions made by Bryan Reasons?
The percentage of profitable transactions made by Bryan Reasons is ―.
    What is the average return per transaction made by Bryan Reasons?
    The average return per transaction made by Bryan Reasons is ―.
      What stocks does Bryan Reasons hold?
      Bryan Reasons holds: AMRX, SCTL, ACRS, MNKKQ, MNKTQ stocks.
        What was Bryan Reasons’s latest transaction?
        Bryan Reasons latest transaction was an Uninformative Buy of $4.80K.
          What was Bryan Reasons's most profitable transaction?
          Bryan Reasons’s most profitable transaction was an Informative Buy of MNKKQ stock on June 7, 2019. The return on the trade was -69.60%.
            What is Bryan Reasons's role in Amneal Pharmaceuticals?
            Bryan Reasons's role in Amneal Pharmaceuticals is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.